How many dependent heroin users are there in Australia?
- Authors
- Hall, W D; Ross, J E; Lynskey, M T; Law, M G; Degenhardt, L J
- Year
- 2000
- Journal
- The Medical journal of Australia
- PMID
- 11194736
- DOI
- 10.5694/j.1326-5377.2000.tb139321.x
OBJECTIVE: To estimate the prevalence of dependent or daily heroin users in Australia, and to compare the prevalence in Australia with that in other developed countries. DESIGN: We applied three different methods of estimation (back-projection, capture-recapture, and multiplier) to data on national opioid overdose deaths in Australia, first-time entrants to methadone maintenance treatment, and heroin-related arrests in New South Wales. We compared our estimates with estimates derived by similar methods in countries of the European Union. DATA SOURCES: Data on national opioid overdose deaths were obtained from the Australian Bureau of Statistics. Data on methadone entrants in NSW were extracted from a database maintained by the NSW Department of Health. Data on arrests for heroin-related offences were supplied by the NSW Police Service. RESULTS: The best estimates of the number of dependent heroin users in Australia in 1997-1998 from the three methods of estimation were between 67 000 and 92 000 and the median estimate was 74 000. The population prevalence was 6.9 per 1000 adults aged 15-54 years. The prevalence of heroin dependence in Australia is the same as that in Britain (7 per 1000) and within the range of recently derived estimates in the European Union (3-8 per 1000 adults aged 15-54 years). CONCLUSIONS: Although the exact figures need to be interpreted with caution, our estimates suggest that Australia has a substantial public health problem with dependent heroin use that is of a magnitude similar to that in comparable European societies.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Evidence of CNIH3 involvement in opioid dependence. | 2016 | 26239289 |
| ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. | 2013 | 23303482 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The Lancet Public Health Commission on gambling. | Wardle H et al. | β | 2024 | β |
| Using the Alcohol, Smoking and Substance Involvement Screening Test to predict substance-related hospitalisation after release from prison: A cohort study. | Cumming C et al. | β | 2024 | β |
| Hidden population size estimation from respondent-driven sampling: a network approach. | Crawford FW et al. | β | 2018 | β |
| Crystalline methamphetamine use and methamphetamine-related harms in Australia. | Degenhardt L et al. | β | 2017 | β |
| Evidence of CNIH3 involvement in opioid dependence. | Nelson EC et al. | β | 2016 | β |
| How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia. | Horyniak D et al. | β | 2015 | β |
| Smoking, posttraumatic stress disorder, and alcohol use disorders in a nationally representative sample of Australian men and women. | Forbes MK et al. | β | 2015 | β |
| Internet search and krokodil in the Russian Federation: an infoveillance study. | Zheluk A et al. | β | 2014 | β |
| ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. | Nelson EC et al. | β | 2013 | β |
| Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10. | Bollaerts K et al. | β | 2013 | β |
| Systematic review of record linkage studies of mortality in ex-prisoners: why (good) methods matter. | Kinner SA et al. | β | 2013 | β |
| An analysis of ethical issues in using wastewater analysis to monitor illicit drug use. | Hall W et al. | β | 2012 | β |
| Estimating the prevalence of illicit opioid use in New York City using multiple data sources. | McNeely J et al. | β | 2012 | β |
| Estimation of the Frequency of Intravenous Drug Users in Hamadan City, Iran, Using the Capture-recapture Method. | Khazaei S et al. | β | 2012 | β |
| Extent of illicit drug use and dependence, and their contribution to the global burden of disease. | Degenhardt L et al. | β | 2012 | β |
| Stimulant use disorders: characteristics and comorbidity in an Australian population sample. | Sara G et al. | β | 2012 | β |
| Counting the cost: estimating the number of deaths among recently released prisoners in Australia. | Kinner SA et al. | β | 2011 | β |
| What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. | Degenhardt L et al. | β | 2011 | β |
| Estimation of the number of injection drug users in St. Petersburg, Russia. | Heimer R et al. | β | 2010 | β |
| Predictors of social anxiety in an opioid dependent sample and a control sample. | Shand FL et al. | β | 2010 | β |
| The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. | Whitham JN et al. | β | 2010 | β |
| The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. | Salmon AM et al. | β | 2010 | β |
| Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria. | Bammer G et al. | β | 2009 | β |
| Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. | Burns L et al. | β | 2009 | β |
| Pregnancy and neonatal characteristics of opioid-dependent Indigenous Australians: a rural and metropolitan comparison. | Tetstall E et al. | β | 2009 | β |
| Reported reasons for initiating drug use among drug-dependent adolescents and youths in Yunnan, China. | Yang L et al. | β | 2009 | β |
| Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. | Hunt RW et al. | β | 2008 | β |
| Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods. | Kimber J et al. | β | 2008 | β |
| Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. | Mathers BM et al. | β | 2008 | β |
| Increased access to opioid substitution treatment in prisons is needed to ensure equivalence of care. | Larney S et al. | β | 2008 | β |
| The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). | Teesson M et al. | β | 2008 | β |
| Alcohol, drugs and Australian young people. | Milne B et al. | β | 2007 | β |
| Harm minimization strategies: opinions of health professionals in rural and remote Australia. | Peterson GM et al. | β | 2007 | β |
| Methadone in pregnancy: treatment retention and neonatal outcomes. | Burns L et al. | β | 2007 | β |
| Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. | Burns L et al. | β | 2007 | β |
| Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002. | Bell J et al. | β | 2006 | β |
| Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). | Fischer B et al. | β | 2006 | β |
| Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users. | Day C et al. | β | 2006 | β |
| The "lessons" of the Australian "heroin shortage". | Degenhardt L et al. | β | 2006 | β |
| Value for money in drug treatment: economic evaluation of prison methadone. | Warren E et al. | β | 2006 | β |
| Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia. | Degenhardt L et al. | β | 2005 | β |
| Effects of a sustained heroin shortage in three Australian States. | Degenhardt L et al. | β | 2005 | β |
| Evaluating explanations of the Australian 'heroin shortage'. | Degenhardt L et al. | β | 2005 | β |
| Process evaluation of an out-patient detoxification service. | Sannibale C et al. | β | 2005 | β |
| The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). | Ross J et al. | β | 2005 | β |
| The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder. | Mills KL et al. | β | 2005 | β |
| The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia. | Day C et al. | β | 2005 | β |
| The impact of illicit drug market changes on health agency operations in Sydney, Australia. | Gibson A et al. | β | 2005 | β |
| Ventilatory responses to hypoxia and hypercapnia in stable methadone maintenance treatment patients. | Teichtahl H et al. | β | 2005 | β |
| Challenges that opioid-dependent women present to the obstetric anaesthetist. | Cassidy B et al. | β | 2004 | β |
| Estimates of chronic hepatitis B virus infection in Australia, 2000. | O'Sullivan BG et al. | β | 2004 | β |
| Estimating the number of drug users in Bangkok 2001: a capture-recapture approach using repeated entries in one list. | BΓΆhning D et al. | β | 2004 | β |
| Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia. | Bartu A et al. | β | 2004 | β |
| Remoteness and issues in mental health care: experience from rural Australia. | Rajkumar S et al. | β | 2004 | β |
| Surveillance for newly acquired hepatitis C in Australia. | Robotin MC et al. | β | 2004 | β |
| The contribution of research to Australian policy responses to heroin dependence 1990-2001: a personal retrospection. | Hall W | β | 2004 | β |
| Contemplating drug monitoring systems in the light of Australia's "heroin shortage". | Topp L et al. | β | 2003 | β |
| Decreased heroin availability in Sydney in early 2001. | Day C et al. | β | 2003 | β |
| Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users. | Lubman D et al. | β | 2003 | β |
| Epidemiology of hepatitis C virus infection in Australia. | Dore GJ et al. | β | 2003 | β |
| Nonfatal heroin overdoses in Queensland, Australia: an analysis of ambulance data. | Clark MJ et al. | β | 2003 | β |
| The ratio of non-fatal to fatal heroin overdose. | Darke S et al. | β | 2003 | β |
| Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). | Darke S et al. | β | 2002 | β |
| Substance misuse in patients with schizophrenia: epidemiology and management. | Kavanagh DJ et al. | β | 2002 | β |